Theratechnologies riding wave of optimism

Shares of Theratechnologies (TSX:TH) jumped Friday after an FDA advisory committee on Thursday evening unanimously recommended the FDA green light the company’s tesamorelin drug to treat excess abdominal fat in HIV-infected patients with lipodystrophy, based on a favourable benefit-risk profile. The stock, which slumped earlier in the week after the committee’s briefing papers suggested Theratechnologies’ [...]